Preliminary experiments indicate conolidine could inhibit specific ion channels, minimizing neuronal excitability and restricting agony signals. This system is particularly applicable in neuropathic agony, where irregular signaling results in persistent discomfort. Also, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to pain perception. Computational ... https://alicex681abv5.wikibyby.com/user